Helping patients find the hepatocellular carcinoma
resources they deserve
How can we help hepatocellular carcinoma patients?
Massive Bio offers an independent cancer treatment analysis as well as free clinical trial matching for hepatocellular carcinoma patients. Our patient advocates work closely with patients to gather information on their current medical status, and then will provide a list of options from available cancer clinical trials close to your home.
We can also provide a comprehensive case analysis through our Virtual Tumor Board from cancer specialists. The Virtual Tumor Board (VTB) is comprised of highly specialized oncologists from nationally-recognized Cancer Centers of Excellence. In just 7-10 days after receiving your medical records, we can get you a treatment plan without having to travel far distances and use your valuable time.
There are approximately 435 clinical trials for Hepatocellular Carcinoma that are currently patients in the United States right now. With such an extensive list, many of them could be beneficial for you. Our team of patient advocates, who are oncology nurses, and our artificial intelligence based clinical trial matching system will find the best option for you.
With just a few clicks, you can see your clinical trial matches now. Click here to use our advanced clinical trial match tool.
Hepatocellular Carcinoma Facts
Sometimes hepatocellular carcinoma patients do not experience symptoms. However, some people will have mild pain in the abdomen, fatigue, and weight loss. Symptoms occur more often in later stages of the disease, especially when the cancer has metastasized. There are roughly 40,000 new liver cancer cases per year in the United States and almost 90% of them consist of hepatocellular carcinoma patients. This cancer is not even in the top 10 most common in the United States even though it is one of the most popular cancer types in the world. This is most likely due to hepatitis B and hepatitis C being much more common in other countries.
Hepatocellular Carcinoma is the most common type of liver cancer. Some risk factors include any long-term diseases of the liver. Hepatitis B and hepatitis C can cause scarring of the liver which can eventually lead to cancer of the liver. Like other cancer types, continuous consumption of alcohol in large amounts can eventually lead to cancer of the liver. Finally, chronic inflammation of the liver and an overload of iron in the body (Hemochromatosis) put patients at risk for Hepatocellular Carcinoma.
Common treatment methods for Hepatocellular Carcinoma include:
Surgery to remove the tumor (Early stage patients)
Liver transplant surgery
Ablation procedure (Extreme heat or cold)
Targeted Drug Therapy
There are several methods to screen patients for Hepatocellular Carcinoma. Blood tests are administered to measure liver function. Biopsies are used to test some of the liver’s tissue. Also some Imaging tests can be used to screen for Hepatocellular Carcinoma like CT scans and MRI’s.
Liver cancer has become much more common in the USA since 1975. Back then, liver cancer occurred in 4.5 people per 100,000. In 2016, there were 8.7 cases per 100,000 people, which is nearly double the amount from 1975. In terms of death rates, they have increased at a slightly lower rate as the number of cases have. In 1975, there were 3.9 deaths per 100,000 people. In 2016, there were 6.7 deaths in 2016.
Hepatocellular Carcinoma is the most common subtype of liver cancer. Other subtypes of liver cancer include:
Intrahepatic bile duct carcinoma
Our team of patient advocates can help guide you to treatment options you might not have been previously aware of. Although you might be new to cancer, we certainly are not. Navigating cancer patients through the tricky path of finding the best treatment is our goal. No two cancer patients are alike, which is why we find treatment for all of our patients based on their specific genomics, location, stage of cancer, and nearly 100 more data points.